As a new subsidiary of SightLife, we’re accelerating our shared mission: to eliminate treatable corneal blindness worldwide by 2040. We’re driving innovations in research, products, therapeutics, prevention and policy to transform the corneal ecosystem.
Presented jointly by the Cornea Society and SightLife Surgical, Demystifying DMEK Through a Skills Transfer Wet Lab will be held May 6 during the 2017 ASCRS Annual Meeting.
We’re committed to leading research efforts and developing new technologies for innovative and affordable therapeutics that will transform the medical care available for those living with corneal blindness.
We’re committed to removing systemic barriers that limit patients’ access to care and surgeons’ ability to provide the best corneal treatments to their patients.
We’re committed to significantly increasing prevention and early treatment solutions, which are critical to eliminating corneal blindness by 2040.